Skip to main content
. 2021 Aug 23;40:263. doi: 10.1186/s13046-021-02054-x

Fig. 2.

Fig. 2

The representative structures of mIDH1/2 inhibitors. The phenyl glycine based AG-120 is an orally available mIDH1 inhibitor (IC50 [IDH1R132H] = 12 nM). The triazines based AG-221 is an orally available mIDH2 inhibitor (IC50 [IDH2R140Q] = 100 nM versus IC50 [IDH2wild-type] = 1.8 μM). AG-881 is a pan-IDH inhibitor against both mIDH1 and mIDH2 (IC50 [IDH1R132H] = 6 nM versus IC50 [IDH2R140Q] = 12 nM)